Interview: SenseAnywhere’s Calibration Laboratory Receives ISO 17025 Accreditation
SenseAnywhere’s Calibration Laboratory is now ISO 17025 accredited. The ISO/IEC 17025 accreditation certificate shows that the company puts great value
Read more
Latest
FDA Grants EUA for Novavax COVID-19 Vaccine, Adjuvanted as a Booster for Adults
The US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for Novavax’s adjuvanted Covid-19 vaccine, NVX-CoV2373, as
Read more
Apogenix’s Asunercept Shows efficacy in Phase II COVID-19 Trial
Apogenix, a biopharmaceutical company developing next-gen immunotherapeutics, announced on Wednesday that asunercept showed statistically meaningful benefits for hospitalized COVID-19 patients
Read more
Pfizer to Pay $11.6 Billion for Migraine Pill Maker Biohaven Pharmaceuticals
Pfizer and Biohaven Pharmaceutical Holding Company announced on Tuesday, that they have struck an agreement under which Pfizer will acquire
Read more
AstraZeneca’s Liver Cancer Treatment Combo Accepted for US Priority Review
Tremelimumab, in conjunction with Imfinzi, has been accepted under priority review for patients with unresectable liver cancer in the United
Read more
FDA Approves Bristol Myers’ Opdualag for Unresectable or Metastatic Melanoma
American multinational pharmaceutical company Bristol Myers Squibb has announced that OpdualagTM , a new, first-in-class, fixed-dose combination of nivolumab and relatlimab, administered as one intravenous infusion,
Read more
Oragenics Announces Positive Data on Intranasal COVID-19 Vaccine Candidate
American biotech Oragenics, Inc. announced on Thursday the posting of a preprint manuscript in bioRxiv (pronounced “bio-archives”) evaluating a novel
Read more
Moderna Starts HIV Vaccine Trial that Uses Breakthrough mRNA Technology
The first doses of an experimental HIV vaccine antigen have been provided in a clinical study at George Washington University
Read more
Moderna’s ‘Spikevax’ COVID-19 Vaccine Gets Full FDA Approval
The U.S. Food and Drug Administration (FDA) has approved a second COVID-19 vaccine developed by Moderna, which will be marketed
Read more
Pfizer and BioNTech Launch Omicron-specific COVID Vaccine Trial
Pfizer and BioNTech announced on Tuesday that a clinical trial in healthy people 18 to 55 years old to assess
Read more